Medtronic plcMDT announced that the FDA has approved a new arm indication for the Guardian Sensor 3 continuous glucose monitor (CGM) used with the MiniMed 670G insulin pump. Notably, the Guardian ...
GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones ...
A new real-world retrospective analysis published in Diabetes Care showed that users of the MiniMed™ 780G system achieved American Diabetes Association (ADA) recommended goals for time-in-range (TIR)— ...
Latest approval expands Medtronic CGM portfolio in the U.S. GALWAY, Ireland, April 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S ...
A real-world retrospective analysis published in Diabetes Care found that Medtronic’s MiniMed 780G insulin system users met ...
Medtronic PLC has received approval to sell a device for diabetes patients that displays insulin levels on Internet-enabled devices and sends text messages to loved ones if something goes wrong. At an ...
(RTTNews) - Medtronic plc. (MDT) announced the U.S. Food and Drug Administration approval for the Simplera Sync sensor for use with the MiniMed 780G system. The MiniMed 780G system now offers more ...
Medtronic plc MDT announced that the FDA has approved a new arm indication for the Guardian Sensor 3 continuous glucose monitor (CGM) used with the MiniMed 670G insulin pump. Notably, the Guardian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback